The UK is a recognised global leader in life sciences and genomics, with research and development driving advances in healthcare, personalised medicine, and disease prevention. From genome sequencing and bioinformatics to the development of genetic therapies and precision diagnostics, UK organisations are pushing the boundaries of biological science and technology.
However, bringing these innovations to life requires solving scientific and technological uncertainties — whether it’s improving sequencing accuracy, interpreting vast data sets, or developing new therapeutic methods. These challenges are exactly what R&D tax relief is designed to support.
If your business is working in the life sciences or genomics sector and investing in innovation that goes beyond established knowledge or techniques, you could be eligible to claim R&D tax relief.
Here are some examples of qualifying activities in life sciences and genomics:
Advancing Genome Sequencing Technologies
Developing or improving sequencing methods, platforms, or analysis techniques to increase speed, reduce costs, or improve accuracy in identifying genetic variations or mutations.
Improving Bioinformatics and Data Interpretation Tools
Creating algorithms, software, or analytical platforms that process large-scale genomic data, helping researchers and clinicians make sense of complex biological information.
Developing Personalised Medicine Solutions
Researching and testing new ways to tailor treatments based on genetic profiles, including companion diagnostics or predictive risk assessment tools for specific conditions.
Engineering Gene Editing and Genetic Engineering Methods
Improving technologies such as CRISPR, gene silencing, or gene therapy techniques to target specific diseases or correct genetic defects, particularly when overcoming delivery or safety challenges.
Solving Biological Sample Handling and Processing Challenges
Developing new methods to preserve, process, or analyse biological samples — such as blood, tissue, or saliva — while maintaining the integrity and reliability of the data.
Advancing Synthetic Biology and Biomanufacturing
Engineering biological systems or pathways to produce novel therapeutics, enzymes, or biomaterials, particularly when scaling from lab to production presents technical barriers.
Meeting Clinical and Regulatory Validation Requirements
Developing life science products or methods that comply with UK regulatory frameworks, such as MHRA approval or UKCA marking, particularly when this requires scientific testing and validation.
Integrating Genomic Data with Healthcare Systems
Developing secure, scalable systems to integrate genomic information into clinical workflows, supporting data-driven healthcare and personalised treatment pathways.
If your organisation is involved in overcoming technical or scientific challenges in life sciences or genomics, you could be eligible for R&D tax relief. This incentive helps UK innovators recover a portion of their development costs, supporting further progress in transforming healthcare, biotechnology, and personalised medicine.